Nexentis Technologies (NXTS) Deferred Taxes (2021 - 2023)
Nexentis Technologies (NXTS) posted Deferred Taxes of $238387.0 for Q4 2023, up 711.72% on a QoQ basis from $29368.0 in Q3 2023, and up 1088.83% year-over-year from $20052.2 in Q4 2022.
Analysis
Nexentis Technologies (NXTS) Deferred Taxes (2021 - 2023) Analysis & Trends
Nexentis Technologies has reported Deferred Taxes for 3 years, with the latest figure at $238387.0 in Q4 2023.
- On a quarterly basis, Deferred Taxes rose 1088.83% year-over-year to $238387.0 in Q4 2023; TTM through Dec 2023 was $173360.0, a 254.67% increase from a year earlier, with the FY2023 full-year figure at $173360.0, up 254.67% from the prior year.
- Deferred Taxes was $238387.0 for Q4 2023 at Nexentis Technologies, up from $29368.0 in the prior quarter.
- The five-year high for Deferred Taxes was $238387.0 in Q4 2023, with the low at -$409105.0 in Q3 2021.
- Average Deferred Taxes over 3 years is -$44927.9, with a median of -$21385.5 recorded in 2022.
- The largest YoY upside for Deferred Taxes was 1088.83% in 2023 against a maximum downside of 159.89% in 2023.
- Over 3 years, Deferred Taxes stood at -$101451.0 in 2021, then surged by 76.24% to -$24108.0 in 2022, then jumped by 1088.83% to $238387.0 in 2023.
- The last three Deferred Taxes figures came in at $238387.0 (Q4 2023), $29368.0 (Q3 2023), and -$75732.0 (Q2 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | -291.00 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -587.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | -69.70 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 194.40 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -27.60 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Nexentis Technologies | 1.40 Mn | -7.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 238,387.00 |
| Sep 30, 2023 | 29,368.00 |
| Jun 30, 2023 | -75,732.00 |
| Mar 31, 2023 | -18,663.00 |
| Dec 31, 2022 | -24,108.00 |
| Sep 30, 2022 | 24,604.00 |
| Jun 30, 2022 | -105,398.00 |
| Mar 31, 2022 | -7,181.00 |
| Dec 31, 2021 | -101,451.00 |
| Sep 30, 2021 | -409,105.00 |